This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Vertex Pharmaceuticals’ CRISPR-based therapy made history as ...

From sagging jowls and sulfurous burps to deflated breasts and surprise pregnancies, the side effects of GLP-1 weight-loss drugs have ranged from subtle to strange. Now, new research suggests that ...

Approximately 9.5 million people globally live with type 1 diabetes, a chronic autoimmune disease where T cells from the body's immune system destroy insulin-producing cells in the pancreas, which are ...

BERLIN, Sept 24 (Reuters) - Mercedes-Benz (MBGn.DE), opens new tab announced changes to its top management on Wednesday, replacing chief technology officer Markus Schaefer with head of production ...

Vizrt has introduced Viz Arena 6, the newest version of its all-in-one live augmented reality (AR) graphics and virtual advertising sports solution. “With this release, we’re expanding on the real ...

A daily pill previously shown to slow the progression of type 1 diabetes has now shown a loss of therapeutic benefit when stopped—affirming the promise of the treatment. In 2023, an Australian trial ...

2-year follow-up of randomised placebo-controlled BANDIT trial shows loss of therapeutic benefit when baricitinib treatment is stopped, justifying its testing in earlier stages of type 1 diabetes to ...

A pill version of semaglutide — the active ingredient in Ozempic and Wegovy — helped people lose more than 13% of their body weight in a late-stage trial, pharmaceutical giant Novo Nordisk announced ...

Amid an ongoing surge in defense tech investing, advanced manufacturing company Divergent Technologies raised $290 million, led by Rochefort Asset Management, to expand production of missile parts and ...

Federal Government has said it will begin production of insulin in Nigeria as part of efforts to reduce dependence on imported drugs and improve access to affordable diabetes treatment. Minister of ...

When someone is diagnosed with diabetes, it’s usually pretty simple which one they have — Type 1 or Type 2. The rate of diabetes has grown worldwide, having surpassed 800 million people a year ago. By ...